Luteolin delays photoreceptor degeneration in a mouse model of retinitis pigmentosa

Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate wh...

Full description

Saved in:
Bibliographic Details
Published inNeural regeneration research Vol. 16; no. 10; pp. 2109 - 2120
Main Authors Liu, Xiao-Bin, Liu, Feng, Liang, Yi-Yao, Yin, Gang, Zhang, Hui-Jun, Mi, Xue-Song, Zhang, Zai-Jun, So, Kwok-Fai, Li, Ang, Xu, Ying
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer India Pvt. Ltd 01.10.2021
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China
Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China
Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China%Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases,Jinan University,Guangzhou,Guangdong Province,China%Department of Ophthalmology,the First Affiliated Hospital of Jinan University,Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate whether luteolin exhibits neuroprotective effects on rod cells in rd10 mice, a slow photoreceptor-degenerative model of retinitis pigmentosa. Luteolin (100 mg/kg) intraperitoneally injected daily from postnatal day 14 (P14) to P25 significantly enhanced the visual performance and retinal light responses of rd10 mice at P25. Moreover, it increased the survival of photoreceptors and improved retinal structure. Mechanistically, luteolin treatment attenuated increases in reactive oxygen species, photoreceptor apoptosis, and reactive gliosis; increased mRNA levels of anti-inflammatory cytokines while lowering that of pro-inflammatory and chemoattractant cytokines; and lowered the ratio of phospho-JNK/JNK. Application of the JNK inhibitor SP600125 exerted a similar protective effect to luteolin, suggesting that luteolin delays photoreceptor degeneration and functional deterioration in rd10 mice through regulation of retinal oxidation and inflammation by inhibiting the JNK pathway. Therefore, luteolin may be useful as a supplementary treatment for retinitis pigmentosa. This study was approved by the Qualified Ethics Committee of Jinan University, China (approval No. IACUC-20181217-02) on December 17, 2018.
AbstractList Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate whether luteolin exhibits neuroprotective effects on rod cells in rd10 mice, a slow photoreceptor-degenerative model of retinitis pigmentosa. Luteolin (100 mg/kg) intraperitoneally injected daily from postnatal day 14 (P14) to P25 significantly enhanced the visual performance and retinal light responses of rd10 mice at P25. Moreover, it increased the survival of photoreceptors and improved retinal structure. Mechanistically, luteolin treatment attenuated increases in reactive oxygen species, photoreceptor apoptosis, and reactive gliosis; increased mRNA levels of anti-inflammatory cytokines while lowering that of pro-inflammatory and chemoattractant cytokines; and lowered the ratio of phospho-JNK/JNK. Application of the JNK inhibitor SP600125 exerted a similar protective effect to luteolin, suggesting that luteolin delays photoreceptor degeneration and functional deterioration in rd10 mice through regulation of retinal oxidation and inflammation by inhibiting the JNK pathway. Therefore, luteolin may be useful as a supplementary treatment for retinitis pigmentosa. This study was approved by the Qualified Ethics Committee of Jinan University, China (approval No. IACUC-20181217-02) on December 17, 2018.
Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate whether luteolin exhibits neuroprotective effects on rod cells in rd10 mice, a slow photoreceptor-degenerative model of retinitis pigmentosa. Luteolin (100 mg/kg) intraperitoneally injected daily from postnatal day 14 (P14) to P25 significantly enhanced the visual performance and retinal light responses of rd10 mice at P25. Moreover, it increased the survival of photoreceptors and improved retinal structure. Mechanistically, luteolin treatment attenuated increases in reactive oxygen species, photoreceptor apoptosis, and reactive gliosis; increased mRNA levels of anti-inflammatory cytokines while lowering that of pro-inflammatory and chemoattractant cytokines; and lowered the ratio of phospho-JNK/JNK. Application of the JNK inhibitor SP600125 exerted a similar protective effect to luteolin, suggesting that luteolin delays photoreceptor degeneration and functional deterioration in rd10 mice through regulation of retinal oxidation and inflammation by inhibiting the JNK pathway. Therefore, luteolin may be useful as a supplementary treatment for retinitis pigmentosa. This study was approved by the Qualified Ethics Committee of Jinan University, China (approval No. IACUC-20181217-02) on December 17, 2018.Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate whether luteolin exhibits neuroprotective effects on rod cells in rd10 mice, a slow photoreceptor-degenerative model of retinitis pigmentosa. Luteolin (100 mg/kg) intraperitoneally injected daily from postnatal day 14 (P14) to P25 significantly enhanced the visual performance and retinal light responses of rd10 mice at P25. Moreover, it increased the survival of photoreceptors and improved retinal structure. Mechanistically, luteolin treatment attenuated increases in reactive oxygen species, photoreceptor apoptosis, and reactive gliosis; increased mRNA levels of anti-inflammatory cytokines while lowering that of pro-inflammatory and chemoattractant cytokines; and lowered the ratio of phospho-JNK/JNK. Application of the JNK inhibitor SP600125 exerted a similar protective effect to luteolin, suggesting that luteolin delays photoreceptor degeneration and functional deterioration in rd10 mice through regulation of retinal oxidation and inflammation by inhibiting the JNK pathway. Therefore, luteolin may be useful as a supplementary treatment for retinitis pigmentosa. This study was approved by the Qualified Ethics Committee of Jinan University, China (approval No. IACUC-20181217-02) on December 17, 2018.
R453%R774.6%Q429+.2; Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial neurotoxicity. Therefore, luteolin holds the potential to be useful for treatment of retinal diseases. The purpose of this study was to investigate whether luteolin exhibits neuroprotective effects on rod cells in rd10 mice, a slow photoreceptor-degenerative model of retinitis pigmentosa. Luteolin (100 mg/kg) intraperitoneally injected daily from postnatal day 14 (P14) to P25 significantly enhanced the visual performance and retinal light responses of rd10 mice at P25. Moreover, it increased the survival of photoreceptors and improved retinal structure. Mechanistically, luteolin treatment attenuated increases in reactive oxygen species, photoreceptor apoptosis, and reactive gliosis;increased mRNA levels of anti-inflammatory cytokines while lowering that of pro-inflammatory and chemoattractant cytokines;and lowered the ratio of phospho-JNK/JNK. Application of the JNK inhibitor SP600125 exerted a similar protective effect to luteolin, suggesting that luteolin delays photoreceptor degeneration and functional deterioration in rd10 mice through regulation of retinal oxidation and inflammation by inhibiting the JNK pathway. Therefore, luteolin may be useful as a supplementary treatment for retinitis pigmentosa. This study was approved by the Qualified Ethics Committee of Jinan University, China (approval No. IACUC-20181217-02) on December 17, 2018.
Audience Academic
Author Zhang, Hui-Jun
Liang, Yi-Yao
Liu, Xiao-Bin
Yin, Gang
Xu, Ying
Zhang, Zai-Jun
So, Kwok-Fai
Liu, Feng
Li, Ang
Mi, Xue-Song
AuthorAffiliation Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China%Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases,Jinan University,Guangzhou,Guangdong Province,China%Department of Ophthalmology,the First Affiliated Hospital of Jinan University,Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China;Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China;Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan Uni
AuthorAffiliation_xml – name: Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China%Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases,Jinan University,Guangzhou,Guangdong Province,China%Department of Ophthalmology,the First Affiliated Hospital of Jinan University,Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China;Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China;Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China;Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China;Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China
– name: 4 Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, Guangdong Province, China
– name: 1 Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong Province, China
– name: 2 Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases, Jinan University, Guangzhou, Guangdong Province, China
– name: 3 Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China
– name: 5 Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, China
Author_xml – sequence: 1
  givenname: Xiao-Bin
  surname: Liu
  fullname: Liu, Xiao-Bin
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong Province
– sequence: 2
  givenname: Feng
  surname: Liu
  fullname: Liu, Feng
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong Province
– sequence: 3
  givenname: Yi-Yao
  surname: Liang
  fullname: Liang, Yi-Yao
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong Province
– sequence: 4
  givenname: Gang
  surname: Yin
  fullname: Yin, Gang
  organization: Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases, Jinan University, Guangzhou, Guangdong Province
– sequence: 5
  givenname: Hui-Jun
  surname: Zhang
  fullname: Zhang, Hui-Jun
  organization: Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province
– sequence: 6
  givenname: Xue-Song
  surname: Mi
  fullname: Mi, Xue-Song
  organization: Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province
– sequence: 7
  givenname: Zai-Jun
  surname: Zhang
  fullname: Zhang, Zai-Jun
  organization: Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases, Jinan University, Guangzhou, Guangdong Province
– sequence: 8
  givenname: Kwok-Fai
  surname: So
  fullname: So, Kwok-Fai
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University; Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, Guangdong Province; Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province
– sequence: 9
  givenname: Ang
  surname: Li
  fullname: Li, Ang
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University; Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, Guangdong Province
– sequence: 10
  givenname: Ying
  surname: Xu
  fullname: Xu, Ying
  organization: Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Ministry of Education CNS Regeneration Collaborative Joint Laboratory, Jinan University, Guangzhou, Guangdong Province; Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33642401$$D View this record in MEDLINE/PubMed
BookMark eNp9kkuL2zAUhU2Z0nm0-65KoJtCSaqXbWlTGEIfA4Eu2q6FLF95lHGkVHIaMr--N5NHJ0MpBl8jfedY9-pcFmchBiiK15RMBCX8A61qPi55LSaccKzPigsq62pcq1Ke4fdh-7y4zHlOSCkV4y-Kc84rwQShF8X32WqA2PswaqE3mzxa3sYhJrCwxIKLHQRIZvAxjBAyo0VcZcA34qPoRgkGH_zgUei7BYQhZvOyeO5Mn-HVvl4VPz9_-jH9Op59-3IzvZ6NbVXyMLZOWlfJqnZSlK2k0tTEEWEoCAJStg1tHXOqZJUpFVQtKx1xTQvQgFK1LPlVcbPzbaOZ62XyC5M2OhqvHxZi6rRJg7c9aNFQwRjUDrgSouGyda5RjHILiklbo9fHnddy1SygtdhJMv2J6elO8Le6i7-15IJzVqHB-53B2gRnQqfncZUCtq_vuzy_z5u5BkYYpYQIivS7_e9S_LWCPOiFzxb63gTAAWsmlJA1Xh1B9O0T9OjMSs4UkXiTf6nOYLs-uIintFtTfV2VTJUU84HU5B8UPi0svMVsOY_rJ4I3j8dynMchQAiQHWBTzDmBOyKU6G1G9TaEehtCvcsoSqonEuuHh4ThYXz_P-F0P-LYD5DyXb9aQ9J4rrsQ1ye68SOdZpQofcg5_wMfb_6F
CitedBy_id crossref_primary_10_1155_2021_5838101
crossref_primary_10_1371_journal_pone_0302742
crossref_primary_10_1002_jnr_25021
crossref_primary_10_3390_antibiotics10111373
crossref_primary_10_1016_j_phymed_2025_156523
crossref_primary_10_3389_fnins_2022_868750
crossref_primary_10_1016_j_jmbbm_2021_105055
crossref_primary_10_4103_1673_5374_330622
crossref_primary_10_1007_s44187_024_00247_9
crossref_primary_10_1039_D3FO02716C
crossref_primary_10_4103_1673_5374_390958
crossref_primary_10_1021_acs_jafc_2c07735
crossref_primary_10_1177_09603271211063165
crossref_primary_10_3390_ijms24032136
Cites_doi 10.1167/iovs.04-0541
10.3389/fncel.2018.00203
10.1016/j.neuroscience.2008.06.042
10.1155/2013/480739
10.1080/10286020.2019.1642329
10.1167/iovs.05-0397
10.1167/iovs.13-12004
10.1016/j.neulet.2004.02.041
10.1016/j.yexcr.2017.06.024
10.1016/j.neuroscience.2014.09.013
10.1016/j.jns.2020.116679
10.1016/j.freeradbiomed.2004.01.001
10.1055/s-2007-967122
10.1016/j.bbrc.2012.12.004
10.1016/j.bcp.2018.06.003
10.1038/aps.2017.143
10.1093/brain/awg171
10.1016/j.neulet.2015.01.018
10.1002/cne.21144
10.5483/BMBRep.2017.50.1.114
10.4049/jimmunol.1900612
10.1046/j.1365-2222.2000.00768.x
10.1096/fj.03-0969fje
10.1167/iovs.11-8790
10.1378/chest.118.2.503
10.1007/s10753-017-0575-8
10.1038/srep17645
10.1155/2018/4623919
10.1093/hmg/ddw275
10.1155/2019/9682318
10.3892/mmr.2015.4287
10.1016/S0140-6736(06)69740-7
10.1038/s41598-017-11391-x
10.1073/pnas.1411248112
10.2147/OTT.S191158
10.1016/j.neuropharm.2014.07.012
10.3390/nu11040771
10.1038/eye.2015.236
10.1167/iovs.61.11.2
10.1016/j.fct.2010.06.029
10.1016/j.exer.2009.06.019
10.1016/S0165-5728(01)00303-4
10.1016/j.exer.2017.07.004
10.1186/1742-2094-7-3
10.1167/iovs.04-1369
10.3390/molecules18078083
10.1016/j.brainres.2006.10.031
10.1016/j.neuroscience.2015.04.060
10.1002/term.2522
10.1016/j.jnutbio.2010.01.011
10.1016/j.neuropharm.2018.06.027
10.1016/j.psyneuen.2019.104580
10.1177/1535370213477985
10.1038/srep07601
10.1007/978-0-387-34817-9_13
10.1016/j.exer.2015.04.015
10.1084/jem.20040819
10.1167/iovs.17-22881
10.1083/jcb.119.3.493
10.1016/j.lfs.2007.09.028
10.1016/j.bbrc.2014.05.036
10.1016/j.visres.2006.11.020
10.1016/j.carbon.2016.11.040
ClassificationCodes R453%R774.6%Q429+.2
ContentType Journal Article
Copyright COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.
2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright: © 2021 Neural Regeneration Research 2021
Copyright_xml – notice: COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.
– notice: 2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: Copyright: © 2021 Neural Regeneration Research 2021
DBID AAYXX
CITATION
NPM
K9.
7X8
2B.
4A8
92I
93N
PSX
TCJ
5PM
DOA
DOI 10.4103/1673-5374.303537
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


ProQuest Health & Medical Complete (Alumni)

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1876-7958
EndPage 2120
ExternalDocumentID oai_doaj_org_article_4b1422e7fe3944b38dffb9213ce928c7
PMC8343326
zgsjzsyj_e202110041
A652951353
33642401
10_4103_1673_5374_303537
10.4103/1673-5374.303537_2109_Luteolin
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: The work was supported by the National Natural Science Foundation of China, Nos. 81470656 (to YX), 82071372 (to AL), 82074169 ; Guangdong Grant Key Technologies for Treatment of Brain Disorders', China, No. 2018B030332001 ; Ningxia Key Research and Development Program Grant (Yinchuan, Ningxia Hui Autonomous Region, China) ; Program of Introducing Talents of Discipline to Universities, China, No. B14036 ; (Outstanding Scholar Program of Bioland Laboratory ); and Science and Technology Program of Guangzhou, No. 202007030012
  funderid: (to XSM); (to YX); (to KFS); (to YX, AL, KFS); (Outstanding Scholar Program of Bioland Laboratory ); (to KFS and AL)
GroupedDBID ---
-SE
-S~
0R~
53G
5RS
5VR
5VS
7X7
8FI
92F
92I
ACGFS
ADBBV
ADJBI
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BENPR
CAJEE
CCEZO
CHBEP
CIEJG
CS3
CW9
DIK
DU5
FA0
FDB
GROUPED_DOAJ
GX1
H13
IAO
IEA
IHR
ITC
KQ8
M2M
M48
M5~
NQ-
O9-
OK1
OVD
PGMZT
PIMPY
Q--
RMW
RPM
TCJ
TEORI
TGQ
U1G
U5O
W3E
WFFXF
--K
123
1B1
4.4
8FJ
AAEDT
AAKAS
AALRI
AAXUO
AAYXX
ABUWG
ABWVN
ACRPL
ADMUD
ADNMO
ADRAZ
ADZCM
AFUIB
CCPQU
CITATION
DWQXO
EBS
EJD
EMOBN
EO8
FYUFA
GNUQQ
HMCUK
HYE
HZ~
IHE
IPNFZ
M41
PHGZM
PHGZT
PSYQQ
RIG
ROL
RPZ
UKHRP
2B.
93N
AAXDM
ABXLX
NPM
K9.
7X8
4A8
PMFND
PSX
5PM
ID FETCH-LOGICAL-c653n-cf8cf6867f845d818a70f04a1e40e88db1df2f9526a59e6d25f0fbdeebe997853
IEDL.DBID M48
ISSN 1673-5374
IngestDate Wed Aug 27 01:31:12 EDT 2025
Thu Aug 21 18:12:30 EDT 2025
Thu May 29 04:06:14 EDT 2025
Fri Jul 11 02:26:26 EDT 2025
Fri Jul 25 22:54:54 EDT 2025
Tue Jun 17 21:16:17 EDT 2025
Tue Jun 10 20:24:50 EDT 2025
Thu Jan 02 22:57:57 EST 2025
Thu Apr 24 22:52:06 EDT 2025
Tue Jul 01 03:20:25 EDT 2025
Tue Jun 17 22:49:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords JNK pathway
luteolin
retinal degeneration
reactive gliosis
photoreceptor
reactive oxygen species
retinitis pigmentosa
apoptosis
anti-inflammation
flavonoid
Language English
License http://creativecommons.org/licenses/by-nc-sa/4.0
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c653n-cf8cf6867f845d818a70f04a1e40e88db1df2f9526a59e6d25f0fbdeebe997853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: Study design: AL, YX; experiment performance: XBL, FL, YYL, GY, HJZ; data analysis: XBL, FL, GY, AL, YX; manuscript preparation: AL, YX; manuscript editing and review: XSM, ZJZ, KFS, AL, YX. All authors approved the final version of the paper.
ORCID 0000-0002-9886-4880
0000-0002-9987-2057
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4103/1673-5374.303537
PMID 33642401
PQID 2532908240
PQPubID 4671210
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_4b1422e7fe3944b38dffb9213ce928c7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8343326
wanfang_journals_zgsjzsyj_e202110041
proquest_miscellaneous_2494875370
proquest_journals_2532908240
gale_infotracmisc_A652951353
gale_infotracacademiconefile_A652951353
pubmed_primary_33642401
crossref_primary_10_4103_1673_5374_303537
crossref_citationtrail_10_4103_1673_5374_303537
wolterskluwer_medknow_10_4103_1673-5374_303537_2109_Luteolin
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20211001
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 20211001
  day: 01
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
– name: Mumbai
PublicationTitle Neural regeneration research
PublicationTitleAlternate Neural Regen Res
PublicationTitle_FL Neural Regeneration Research
PublicationYear 2021
Publisher Wolters Kluwer India Pvt. Ltd
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China
Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China
Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China%Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases,Jinan University,Guangzhou,Guangdong Province,China%Department of Ophthalmology,the First Affiliated Hospital of Jinan University,Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Publisher_xml – name: Wolters Kluwer India Pvt. Ltd
– name: Medknow Publications and Media Pvt. Ltd
– name: Medknow Publications & Media Pvt. Ltd
– name: Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China
– name: Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory),Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
– name: Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China
– name: Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China%Institute of New Drug Research and Guangzhou Key Laboratory of Innovative Chemical Drug Research in Cardio-cerebrovascular Diseases,Jinan University,Guangzhou,Guangdong Province,China%Department of Ophthalmology,the First Affiliated Hospital of Jinan University,Guangzhou,Guangdong Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
– name: Co-Innovation Center of Neuroregeneration,Nantong University,Nantong,Jiangsu Province,China%Guangdong-Hong Kong-Macau Institute of CNS Regeneration,Ministry of Education CNS Regeneration Collaborative Joint Laboratory,Jinan University,Guangzhou,Guangdong Province,China
– name: Wolters Kluwer - Medknow
– name: Wolters Kluwer Medknow Publications
References key-10.4103/1673-5374.303537-37
key-10.4103/1673-5374.303537-36
key-10.4103/1673-5374.303537-39
key-10.4103/1673-5374.303537-38
key-10.4103/1673-5374.303537-31
key-10.4103/1673-5374.303537-30
key-10.4103/1673-5374.303537-33
key-10.4103/1673-5374.303537-32
key-10.4103/1673-5374.303537-35
key-10.4103/1673-5374.303537-34
key-10.4103/1673-5374.303537-48
key-10.4103/1673-5374.303537-47
key-10.4103/1673-5374.303537-49
key-10.4103/1673-5374.303537-40
key-10.4103/1673-5374.303537-42
key-10.4103/1673-5374.303537-41
key-10.4103/1673-5374.303537-44
key-10.4103/1673-5374.303537-43
key-10.4103/1673-5374.303537-46
key-10.4103/1673-5374.303537-45
key-10.4103/1673-5374.303537-15
key-10.4103/1673-5374.303537-59
key-10.4103/1673-5374.303537-14
key-10.4103/1673-5374.303537-58
key-10.4103/1673-5374.303537-17
key-10.4103/1673-5374.303537-16
key-10.4103/1673-5374.303537-19
key-10.4103/1673-5374.303537-18
key-10.4103/1673-5374.303537-51
key-10.4103/1673-5374.303537-50
key-10.4103/1673-5374.303537-53
key-10.4103/1673-5374.303537-52
key-10.4103/1673-5374.303537-11
key-10.4103/1673-5374.303537-55
key-10.4103/1673-5374.303537-10
key-10.4103/1673-5374.303537-54
key-10.4103/1673-5374.303537-13
key-10.4103/1673-5374.303537-57
key-10.4103/1673-5374.303537-12
key-10.4103/1673-5374.303537-56
key-10.4103/1673-5374.303537-1
key-10.4103/1673-5374.303537-2
key-10.4103/1673-5374.303537-3
key-10.4103/1673-5374.303537-4
key-10.4103/1673-5374.303537-9
key-10.4103/1673-5374.303537-26
key-10.4103/1673-5374.303537-25
key-10.4103/1673-5374.303537-28
key-10.4103/1673-5374.303537-27
key-10.4103/1673-5374.303537-5
key-10.4103/1673-5374.303537-6
key-10.4103/1673-5374.303537-29
key-10.4103/1673-5374.303537-7
key-10.4103/1673-5374.303537-8
key-10.4103/1673-5374.303537-62
key-10.4103/1673-5374.303537-61
key-10.4103/1673-5374.303537-20
key-10.4103/1673-5374.303537-64
key-10.4103/1673-5374.303537-63
key-10.4103/1673-5374.303537-22
key-10.4103/1673-5374.303537-21
key-10.4103/1673-5374.303537-24
key-10.4103/1673-5374.303537-23
key-10.4103/1673-5374.303537-60
References_xml – ident: key-10.4103/1673-5374.303537-40
  doi: 10.1167/iovs.04-0541
– ident: key-10.4103/1673-5374.303537-45
  doi: 10.3389/fncel.2018.00203
– ident: key-10.4103/1673-5374.303537-4
  doi: 10.1016/j.neuroscience.2008.06.042
– ident: key-10.4103/1673-5374.303537-41
  doi: 10.1155/2013/480739
– ident: key-10.4103/1673-5374.303537-54
  doi: 10.1080/10286020.2019.1642329
– ident: key-10.4103/1673-5374.303537-31
  doi: 10.1167/iovs.05-0397
– ident: key-10.4103/1673-5374.303537-15
  doi: 10.1167/iovs.13-12004
– ident: key-10.4103/1673-5374.303537-50
  doi: 10.1016/j.neulet.2004.02.041
– ident: key-10.4103/1673-5374.303537-59
  doi: 10.1016/j.yexcr.2017.06.024
– ident: key-10.4103/1673-5374.303537-12
  doi: 10.1016/j.neuroscience.2014.09.013
– ident: key-10.4103/1673-5374.303537-52
  doi: 10.1016/j.jns.2020.116679
– ident: key-10.4103/1673-5374.303537-53
  doi: 10.1016/j.freeradbiomed.2004.01.001
– ident: key-10.4103/1673-5374.303537-16
– ident: key-10.4103/1673-5374.303537-64
  doi: 10.1055/s-2007-967122
– ident: key-10.4103/1673-5374.303537-38
  doi: 10.1016/j.bbrc.2012.12.004
– ident: key-10.4103/1673-5374.303537-58
  doi: 10.1016/j.bcp.2018.06.003
– ident: key-10.4103/1673-5374.303537-27
  doi: 10.1038/aps.2017.143
– ident: key-10.4103/1673-5374.303537-36
  doi: 10.1093/brain/awg171
– ident: key-10.4103/1673-5374.303537-57
  doi: 10.1016/j.neulet.2015.01.018
– ident: key-10.4103/1673-5374.303537-10
  doi: 10.1002/cne.21144
– ident: key-10.4103/1673-5374.303537-1
  doi: 10.5483/BMBRep.2017.50.1.114
– ident: key-10.4103/1673-5374.303537-60
  doi: 10.4049/jimmunol.1900612
– ident: key-10.4103/1673-5374.303537-25
  doi: 10.1046/j.1365-2222.2000.00768.x
– ident: key-10.4103/1673-5374.303537-17
  doi: 10.1096/fj.03-0969fje
– ident: key-10.4103/1673-5374.303537-34
  doi: 10.1167/iovs.11-8790
– ident: key-10.4103/1673-5374.303537-8
  doi: 10.1378/chest.118.2.503
– ident: key-10.4103/1673-5374.303537-46
  doi: 10.1007/s10753-017-0575-8
– ident: key-10.4103/1673-5374.303537-22
  doi: 10.1038/srep17645
– ident: key-10.4103/1673-5374.303537-28
  doi: 10.1155/2018/4623919
– ident: key-10.4103/1673-5374.303537-49
  doi: 10.1093/hmg/ddw275
– ident: key-10.4103/1673-5374.303537-37
  doi: 10.1155/2019/9682318
– ident: key-10.4103/1673-5374.303537-21
  doi: 10.3892/mmr.2015.4287
– ident: key-10.4103/1673-5374.303537-14
  doi: 10.1016/S0140-6736(06)69740-7
– ident: key-10.4103/1673-5374.303537-20
  doi: 10.1038/s41598-017-11391-x
– ident: key-10.4103/1673-5374.303537-23
  doi: 10.1073/pnas.1411248112
– ident: key-10.4103/1673-5374.303537-61
  doi: 10.2147/OTT.S191158
– ident: key-10.4103/1673-5374.303537-35
  doi: 10.1016/j.neuropharm.2014.07.012
– ident: key-10.4103/1673-5374.303537-44
  doi: 10.3390/nu11040771
– ident: key-10.4103/1673-5374.303537-26
  doi: 10.1038/eye.2015.236
– ident: key-10.4103/1673-5374.303537-43
  doi: 10.1167/iovs.61.11.2
– ident: key-10.4103/1673-5374.303537-7
  doi: 10.1016/j.fct.2010.06.029
– ident: key-10.4103/1673-5374.303537-3
  doi: 10.1016/j.exer.2009.06.019
– ident: key-10.4103/1673-5374.303537-32
  doi: 10.1016/S0165-5728(01)00303-4
– ident: key-10.4103/1673-5374.303537-62
  doi: 10.1016/j.exer.2017.07.004
– ident: key-10.4103/1673-5374.303537-9
  doi: 10.1186/1742-2094-7-3
– ident: key-10.4103/1673-5374.303537-13
  doi: 10.1167/iovs.04-1369
– ident: key-10.4103/1673-5374.303537-55
  doi: 10.3390/molecules18078083
– ident: key-10.4103/1673-5374.303537-2
  doi: 10.1016/j.brainres.2006.10.031
– ident: key-10.4103/1673-5374.303537-33
  doi: 10.1016/j.neuroscience.2015.04.060
– ident: key-10.4103/1673-5374.303537-19
  doi: 10.1002/term.2522
– ident: key-10.4103/1673-5374.303537-24
  doi: 10.1016/j.jnutbio.2010.01.011
– ident: key-10.4103/1673-5374.303537-56
  doi: 10.1016/j.neuropharm.2018.06.027
– ident: key-10.4103/1673-5374.303537-63
  doi: 10.1016/j.psyneuen.2019.104580
– ident: key-10.4103/1673-5374.303537-30
  doi: 10.1177/1535370213477985
– ident: key-10.4103/1673-5374.303537-51
  doi: 10.1038/srep07601
– ident: key-10.4103/1673-5374.303537-42
  doi: 10.1007/978-0-387-34817-9_13
– ident: key-10.4103/1673-5374.303537-48
  doi: 10.1016/j.exer.2015.04.015
– ident: key-10.4103/1673-5374.303537-18
  doi: 10.1084/jem.20040819
– ident: key-10.4103/1673-5374.303537-29
  doi: 10.1167/iovs.17-22881
– ident: key-10.4103/1673-5374.303537-11
  doi: 10.1083/jcb.119.3.493
– ident: key-10.4103/1673-5374.303537-6
  doi: 10.1016/j.lfs.2007.09.028
– ident: key-10.4103/1673-5374.303537-39
  doi: 10.1016/j.bbrc.2014.05.036
– ident: key-10.4103/1673-5374.303537-5
  doi: 10.1016/j.visres.2006.11.020
– ident: key-10.4103/1673-5374.303537-47
  doi: 10.1016/j.carbon.2016.11.040
SSID ssj0058923
Score 2.300696
Snippet Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit microglial...
R453%R774.6%Q429+.2; Luteolin is neuroprotective for retinal ganglion cells and retinal pigment epithelial cells after oxidative injury, whereby it can inhibit...
SourceID doaj
pubmedcentral
wanfang
proquest
gale
pubmed
crossref
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2109
SubjectTerms anti-inflammation; apoptosis; flavonoid; jnk pathway; luteolin; photoreceptor; reactive gliosis; reactive oxygen species; retinal degeneration; retinitis pigmentosa
Bioflavonoids
Care and treatment
Cell receptors
Cytokines
Degeneration (Pathology)
Development and progression
Flavones
Flavonoids
Genetic aspects
Health aspects
Photoreceptors
Reactive oxygen species
Retinitis pigmentosa
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuCCiPQIuMVIE4hE38jsRlQVQVAi5QqTcrceztgyZVs1W1_fWdcbJhAxJcuNpjx_aMZzL2-BtC9iolgzE8T8H4i1SYEFLjPUvLzNWKO-lzj-cdX7-pg0Px-UgebaT6wpiwHh64X7iZiKcUXgePTzgrbuoQqoLl3PmCGRffkYPNWztTvQ6WpoiJ3XKleSq5Fv0FpcgzPhvL3oH2lpj_fMMgRdz-P7Xzhnn6PXTy7nXZhLJZQM11ixfc3VmMb9-wUvsPyP3h95LO-2k9JHd884hszxtwrc9X9DWNAZ_xJH2bfP9ytfSYs4ciUuSqoxfHLXjgHgNd2ksoXERIauQcBaKS4imBpzF3Dm0DxfePGHoEDU8WeMjYduVjcrj_6cfHg3TIsZA6JXmTumBcUEbpYISswXqXOguZKHMvMm9MXeV1YKGQTJWy8KpmMmShqj3wvgAHVPInZKtpG_-M0IoJrVxR59CnYBkiG2nQnpU3uoJOWEJm64W2bgAgxzwYPy04Isgai6yxyBrbsyYhb8cWFz34xl9oPyDvRjqEzY4FIEx2ECb7L2FKyBvkvMXNDUNz5fBGASaIMFl2rvBeFFOFJGRnQgmb0k2r17JjB6XQWSY5wwzzIkvIq7EaW2KgW-OBiZYhXA-4kBponvaiNk6Jc3AWwR9OiJ4I4WTO05rm5DhChhuOOHUqIXuDuP4a1c2iO73pVqfWs4xFAEH4wPuJLNvz_mnmZPHTjcW3LM8Ku5ba5_-DFS_IPRxPHze5Q7aWl1d-F_7_ltXLuNVvAZSTVMQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Medknow Open Access Medical Journals
  dbid: W3E
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIiQuCCiPQEFBqkAcQhO_4ihwKKhVhQoXqNSblTj2dluaVJtdVdtfz4zzYAMSF26RX7E9M7bHnvmGkL1SCqcUSyLY_HnElXORspZGRWwqyYywicX7jq_f5PEp_3ImzrbIoPV7m_3FokOJ6GCCuwn0bl2diMqURYKlPF8DL4BKTJN8kGSZ972N80Ee4yy3_SeN82IFZ9Llx5P5KvegRKDs36EpqADoi8IOhzVcqMwHhhv_1T1w8iRm-2Pae1j9BcZP39jQPO7_36v7xvb2p-nl3ZuidkU9g5ybBh_I20tvH7-xyx09IPf742l40E3HQ7Jl60dk56AG1fxqHb4JvcGov4nfId9PVkuLMX9CRJpct-H1eQMavEVDmWYBiTMPaY2UD6FQEeItgw197J2wcSH6T6LpElScz_CSsmmLx-T06PDH5-Ooj9EQGSlYHRmnjJNKpk5xUcHuX6Sxi3mRWB5bpaoyqRx1maCyEJmVFRUudmVlgXcyUGAFe0K266a2z0hYUp5Kk1UJtMlpjMhIKay-pVVpCY3QgOwPE61ND2COcTR-alBkkDQaSaORNLojTUDejTWuO_COf5T9hLQbyyHstk8AJtQ9E2rur8xs6iz6E5dMVc6VGU2YsRlVBhp5i5TXuDhA10zR-zjAABFmSx9IfFfFUCMB2Z2UBKE20-yBd3S_qLSaCkYxQj2PA_J6zMaaaChXWyCipgj3AypoCmWedqw2DokxUDZBnw5IOmHCyZinOfX83EOOK4Y4dzIgez27_u7V7ay9uG3XF9qiKCIAIfzgw4SX9VXn2jmZ_Ghj8jXKqR649vn_VX9B7mFPOovLXbK9XKzsSzg5LstXXsh_AXkPaG0
  priority: 102
  providerName: Wolters Kluwer Health
Title Luteolin delays photoreceptor degeneration in a mouse model of retinitis pigmentosa
URI http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=10;spage=2109;epage=2120;aulast=Liu;type=0
https://www.ncbi.nlm.nih.gov/pubmed/33642401
https://www.proquest.com/docview/2532908240
https://www.proquest.com/docview/2494875370
https://d.wanfangdata.com.cn/periodical/zgsjzsyj-e202110041
https://pubmed.ncbi.nlm.nih.gov/PMC8343326
https://doaj.org/article/4b1422e7fe3944b38dffb9213ce928c7
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdgCIkXBIyPsDEZaQLxkC7xVxwJCRW0aUKMF6jYm5UPu9vYkq3pNLq_njsnzRqYEC-tFJ-d2Hf2-c7n3xGynSvptOZxCMpfhEI7F2prWZhFRal4IW1s0d9x8FXtT8TnQ3l4cz26G8DmVtMO80lNZqejXxeLDzDhYf86EnHEd2KV8FDyRIxgPYb_u-Qe6KUE8xkciP5MQerUJ3vrqdtDy1tbGCgpj-X_94q9orL-DKe8f5VVLqumUHJV46F389PHvK9orr1H5GG35aTjVkYekzu2ekLWxxWY22cL-ob6IFDvXV8n375czi3m8aGIHrlo6PlRDVa5xeCXegYPpx6mGrlJgSij6Dmw1OfTobWjeCcSw5Gg4vEUHY91kz0lk73d75_2wy7vQlgoyauwcLpwSqvEaSFL0OhZErlIZLEVkdW6zOPSMZdKpjKZWlUy6SKXlxbkIQWjVPJnZK2qK_uC0JyJRBVpGUObgkWIdpTAippbneTQCAvIznKgTdGBkmNujFMDxgmyxiBrDLLGtKwJyLu-xnkLyPEP2o_Iu54OobT9g3o2Nd3MNMK7wWziLN4RzrkunctTFvPCpkwX0Mhb5LxBEYRPK7Lu3gJ0EKGzzFjhWSmmDwnI5oASJmoxLF7KjlnKuWGSM8w6L6KAvO6LsSYGv1UWmGgYQviAWZkAzfNW1PoucQ4GJNjIAUkGQjjo87CkOj7yMOKaI3adCsh2J643X3U9bU6um8WJsSxiHlQQXvB-IMvmrL2uORj8cGXwDYuj1Cyl9uV_9G6DPMDXtaGSm2RtPru0r2DLN8-3vKtky89n-P3Bd38Dyc1Smw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Luteolin+delays+photoreceptor+degeneration+in+a+mouse+model+of+retinitis+pigmentosa&rft.jtitle=Neural+regeneration+research&rft.au=Liu%2C+Xiao-Bin&rft.au=Liu%2C+Feng&rft.au=Liang%2C+Yi-Yao&rft.au=Yin%2C+Gang&rft.date=2021-10-01&rft.issn=1673-5374&rft.volume=16&rft.issue=10&rft.spage=2109&rft_id=info:doi/10.4103%2F1673-5374.303537&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgsjzsyj-e%2Fzgsjzsyj-e.jpg